779 studies found for:    "Hypertension, Pulmonary"
Show Display Options
Download search resultsDownload the search results for:
"Hypertension, Pulmonary" (779 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Hypertension, Pulmonary
Intervention: Other: Correlation assessment
2 Unknown  Simvatstatin Used to Treat Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: simvastatin
3 Unknown  Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Conditions: Chronic Obstructive Pulmonary Disease;   Hypertension, Pulmonary
Intervention: Drug: DHEA Treatment
4 Completed Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
5 Active, not recruiting Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Conditions: Chronic Obstructive Pulmonary Disease;   Hypertension, Pulmonary
Interventions: Drug: DHEA treatment;   Drug: Placebo
6 Completed Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
7 Completed
Has Results
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
Conditions: Thalassemia;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil
8 Completed Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Conditions: Pulmonary Fibrosis;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil (50 mg)
9 Completed Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
Conditions: Heart Failure, Diastolic;   Hypertension, Pulmonary
Interventions: Drug: bosentan;   Drug: placebo
10 Recruiting Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
11 Recruiting Effect of Exercise Training in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Behavioral: respiratory and exercise therapy;   Behavioral: respiratory and exercise therapy with supplemental oxygen
12 Completed Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Intervention: Drug: IK-3001
13 Terminated A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Placebo
14 Completed
Has Results
Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.
Conditions: Hypertension, Pulmonary;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Riociguat (Adempas, BAY63-2521) 1.0 mg;   Drug: Riociguat (Adempas, BAY63-2521) 2.5 mg
15 Active, not recruiting
Has Results
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
16 Completed An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
17 Completed Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
18 Active, not recruiting Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
19 Terminated Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Terbogrel
20 Completed Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Terbogrel low dose;   Drug: Terbogrel high dose;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years